Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jayasundar, R; Hall, LD; Bleehen, NM
   RF coils for combined MR and hyperthermia studies: I. Hyperthermia applicator as an MR coil
   MAGNETIC RESONANCE IMAGING
   
   R. Jayasundar et al., "RF coils for combined MR and hyperthermia studies: I. Hyperthermia applicator as an MR coil", MAGN RES IM, 19(1), 2001, pp. 111-116
2. Jayasundar, R; Hall, LD; Bleehen, NM
   RF coils for combined MR and hyperthermia studies: II. MR coil as an hyperthermic applicator
   MAGNETIC RESONANCE IMAGING
   
   R. Jayasundar et al., "RF coils for combined MR and hyperthermia studies: II. MR coil as an hyperthermic applicator", MAGN RES IM, 19(1), 2001, pp. 117-122
3. Jayasundar, R; Honess, D; Hall, LD; Bleehen, NM
   Simultaneous evaluation of the effects of RF hyperthermia on the intra- and extracellular tumor pH
   MAGNETIC RESONANCE IN MEDICINE
   
   R. Jayasundar et al., "Simultaneous evaluation of the effects of RF hyperthermia on the intra- and extracellular tumor pH", MAGN RES M, 43(1), 2000, pp. 1-8
4. Mead, GM; Bleehen, NM; Gregor, A; Bullimore, J; Murrell, DS; Rampling, RP; Roberts, JT; Glaser, MG; Lantos, P; Ironside, JW; Moss, TH; Brada, M; Whaley, JB; Stenning, SP
   A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma - Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy
   CANCER
   
   G.M. Mead et al., "A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma - Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy", CANCER, 89(6), 2000, pp. 1359-1370
5. Jayasundar, R; Hall, ED; Bleehen, NM
   Magnetic resonance, hyperthermia and oncology
   CURRENT SCIENCE
   
   R. Jayasundar et al., "Magnetic resonance, hyperthermia and oncology", CURRENT SCI, 76(6), 1999, pp. 794-799
6. Twelves, CJ; Gardner, C; Flavin, A; Sludden, J; Dennis, I; de Bono, J; Beale, P; Vasey, P; Hutchison, C; Macham, MA; Rodriguez, A; Judson, I; Bleehen, NM
   Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
   BRITISH JOURNAL OF CANCER
   
   C.J. Twelves et al., "Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II", BR J CANC, 80(11), 1999, pp. 1786-1791
7. FORD J; OSBORN C; BARTON T; BLEEHEN NM
   A PHASE-I STUDY OF INTRAVENOUS RMP-7 WITH CARBOPLATIN IN PATIENTS WITH PROGRESSION OF MALIGNANT GLIOMA
   European journal of cancer
   
   J. Ford et al., "A PHASE-I STUDY OF INTRAVENOUS RMP-7 WITH CARBOPLATIN IN PATIENTS WITH PROGRESSION OF MALIGNANT GLIOMA", European journal of cancer, 34(11), 1998, pp. 1807-1811
8. MIDDLETON MR; LUNN JM; MORRIS C; RUSTIN G; WEDGE SR; BRAMPTON MH; LIND MJ; LEE SM; NEWELL DR; BLEEHEN NM; NEWLANDS ES; CALVERT AH; MARGISON GP; THATCHER N
   O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA
   British Journal of Cancer
   
   M.R. Middleton et al., "O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA", British Journal of Cancer, 78(9), 1998, pp. 1199-1202
9. HAWKINS RE; RUSSELL SJ; MARCUS R; ASHWORTH LJ; BRISSNIK J; ZHANG J; WINTER G; BLEEHEN NM; STEVENSON F; HAMBLIN T; OSCIER D; ZHU DL; KING C; KUMAR S; THOMPSETT A; STEVENSON GT
   A PILOT-STUDY OF IDIOTYPIC VACCINATION FOR FOLLICULAR B-CELL LYMPHOMAUSING A GENETIC APPROACH
   Human gene therapy
   
   R.E. Hawkins et al., "A PILOT-STUDY OF IDIOTYPIC VACCINATION FOR FOLLICULAR B-CELL LYMPHOMAUSING A GENETIC APPROACH", Human gene therapy, 8(10), 1997, pp. 1287-1299
10. JAYASUNDAR R; HALL LD; BLEEHEN NM
    THE EFFECTS OF ANESTHESIA AND PHYSICAL RESTRAINT ON INTRACELLULAR ANDEXTRACELLULAR TUMOR PH, TUMOR TEMPERATURE AND BIOENERGETICS IN MURINERIF-1 TUMORS
    Magnetic resonance imaging
    
    R. Jayasundar et al., "THE EFFECTS OF ANESTHESIA AND PHYSICAL RESTRAINT ON INTRACELLULAR ANDEXTRACELLULAR TUMOR PH, TUMOR TEMPERATURE AND BIOENERGETICS IN MURINERIF-1 TUMORS", Magnetic resonance imaging, 15(7), 1997, pp. 847-855
11. BOWER M; NEWLANDS ES; BLEEHEN NM; BRADA M; BEGENT RJH; CALVERT H; COLQUHOUN I; LEWIS P; BRAMPTON MH
    MULTICENTER CRC PHASE-II TRIAL OF TEMOZOLOMIDE IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA
    Cancer chemotherapy and pharmacology
    
    M. Bower et al., "MULTICENTER CRC PHASE-II TRIAL OF TEMOZOLOMIDE IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA", Cancer chemotherapy and pharmacology, 40(6), 1997, pp. 484-488
12. BOOTE DJ; DENNIS IF; TWENTYMAN PR; OSBORNE RJ; LABURTE C; HENSEL S; SMYTH JF; BRAMPTON MH; BLEEHEN NM
    PHASE-I STUDY OF ETOPOSIDE WITH SDZ PSC 833 AS A MODULATOR OF MULTIDRUG-RESISTANCE IN PATIENTS WITH CANCER
    Journal of clinical oncology
    
    D.J. Boote et al., "PHASE-I STUDY OF ETOPOSIDE WITH SDZ PSC 833 AS A MODULATOR OF MULTIDRUG-RESISTANCE IN PATIENTS WITH CANCER", Journal of clinical oncology, 14(2), 1996, pp. 610-618
13. GIRLING DJ; THATCHER N; CLARK PI; HOPWOOD P; TWIDDY S; STEPHENS RJ; BAILEY AJ; MACHIN D; BLEEHEN NM; BOLGER JJ; CONNOLLY CK; HASLETON PS; MACBETH FR; MOGHISSI K; SAUNDERS MI; WHITE RJ; ALCOCK S; BURT H; CROSSLEY E; DECKER E; ENGLISH J; FOSTER G; HANNIGAN K; HERON D; HUTCHINSON J; LOMAX L; MERCER V; PAGE S; ROTHWELL T; STAINES K; TAYLORNEAL P; TURNBALL V; AXFORD AT; EARL HM; GLAHOLM J; FALK SJ; GRAHAM JD; JONES DK; COOMBES RC; EPSTEIN RJ; HANHAM I; LOWDELL CP; NEWLANDS E; SMITH DB; COOKSON JB; ANDERSON H; GRIBBIN HR; SINCLAIR DJM; CARMICHAEL J; CHAN SYT; JOHNSTON IDA; MORGAN SA; DUNN KS; MANIFOLD IH; RADSTONE DJ; LAMONT A; ROBINSON ACR; BISSETT D; NICOLSON MC; TANG OT; SINNAMON DG; VARGHESE G; BIBBY RJ; OREILLY JF; BATH JCJ; BREDIN CP; STEWART SJ; WHILLIS D; WILTSHIRE CR; MCILLMURRAY MB; BOND MG; WARDMAN AG; BOZZINO JM; FERGUSON GC; MACMILLAN CH; SUGDEN EM; TALBOT DC; QUIGLEY IG; WEATHERSTONE RM; VEALE D; OREGAN PF
    COMPARISON OF ORAL ETOPOSIDE AND STANDARD INTRAVENOUS MULTIDRUG CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A STOPPED MULTICENTER RANDOMIZED TRIAL
    Lancet
    
    D.J. Girling et al., "COMPARISON OF ORAL ETOPOSIDE AND STANDARD INTRAVENOUS MULTIDRUG CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER - A STOPPED MULTICENTER RANDOMIZED TRIAL", Lancet, 348(9027), 1996, pp. 563-566
14. BLEEHEN NM; GIRLING DJ; HOPWOOD P; LALLEMAND G; MACHIN D; STEPHENS RJ; BAILEY AJ
    RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS (VOL 73, PG 406, 1996)
    British Journal of Cancer
    
    N.M. Bleehen et al., "RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS (VOL 73, PG 406, 1996)", British Journal of Cancer, 74(6), 1996, pp. 997-997
15. STEPHENS RJ; GIRLING DJ; BLEEHEN NM; MOGHISSI K; YOSEF HMA; MACHIN D
    THE ROLE OF POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED TRIAL IN PATIENTS WITH PATHOLOGICALLY STAGED T1-2N1-2,M(0) DISEASE
    British Journal of Cancer
    
    R.J. Stephens et al., "THE ROLE OF POSTOPERATIVE RADIOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A MULTICENTER RANDOMIZED TRIAL IN PATIENTS WITH PATHOLOGICALLY STAGED T1-2N1-2,M(0) DISEASE", British Journal of Cancer, 74(4), 1996, pp. 632-639
16. HONESS DJ; KITAMOTO Y; RAMPLING MR; BLEEHEN NM
    NICOTINAMIDE AND PENTOXIFYLLINE INCREASE HUMAN-LEUKOCYTE FILTERABILITY - A POSSIBLE MECHANISM FOR REDUCTION OF ACUTE-HYPOXIA
    British Journal of Cancer
    
    D.J. Honess et al., "NICOTINAMIDE AND PENTOXIFYLLINE INCREASE HUMAN-LEUKOCYTE FILTERABILITY - A POSSIBLE MECHANISM FOR REDUCTION OF ACUTE-HYPOXIA", British Journal of Cancer, 74, 1996, pp. 236-240
17. BLEEHEN NM; GIRLING DJ; HOPWOOD P; LALLEMAND G; MACHIN D; STEPHENS RJ; BAILEY AJ
    RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS
    British Journal of Cancer
    
    N.M. Bleehen et al., "RANDOMIZED TRIAL OF 4-DRUG VS LESS INTENSIVE 2-DRUG CHEMOTHERAPY IN THE PALLIATIVE TREATMENT OF PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)AND POOR-PROGNOSIS", British Journal of Cancer, 73(3), 1996, pp. 406-413
18. REEVE JG; MORGAN J; CLARK PMS; BLEEHEN NM
    INSULIN-LIKE GROWTH-FACTOR (IGF) AND IGF BINDING-PROTEINS IN GROWTH-HORMONE DYSREGULATION AND ABNORMAL GLUCOSE-TOLERANCE IN SMALL-CELL LUNG-CANCER PATIENTS
    European journal of cancer
    
    J.G. Reeve et al., "INSULIN-LIKE GROWTH-FACTOR (IGF) AND IGF BINDING-PROTEINS IN GROWTH-HORMONE DYSREGULATION AND ABNORMAL GLUCOSE-TOLERANCE IN SMALL-CELL LUNG-CANCER PATIENTS", European journal of cancer, 31A(9), 1995, pp. 1455-1460
19. BLEEHEN NM; NEWLANDS ES; LEE SM; THATCHER N; SELBY P; CALVERT AH; RUSTIN GJS; BRAMPTON M; STEVENS MFG
    CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATICMELANOMA
    Journal of clinical oncology
    
    N.M. Bleehen et al., "CANCER-RESEARCH CAMPAIGN PHASE-II TRIAL OF TEMOZOLOMIDE IN METASTATICMELANOMA", Journal of clinical oncology, 13(4), 1995, pp. 910-913
20. HONESS DJ; ANDREWS MS; WARD R; BLEEHEN NM
    PENTOXIFYLLINE INCREASES RIF-1 TUMOR PO(2) IN A MANNER COMPATIBLE WITH ITS ABILITY TO INCREASE RELATIVE TUMOR PERFUSION
    Acta oncologica
    
    D.J. Honess et al., "PENTOXIFYLLINE INCREASES RIF-1 TUMOR PO(2) IN A MANNER COMPATIBLE WITH ITS ABILITY TO INCREASE RELATIVE TUMOR PERFUSION", Acta oncologica, 34(3), 1995, pp. 385-389
21. FREW DG; DOBSON JM; STENNING SP; BLEEHEN NM
    RESPONSE OF 145 SPONTANEOUS CANINE HEAD AND NECK TUMORS TO RADIATION VERSUS RADIATION PLUS MICROWAVE HYPERTHERMIA - RESULTS OF A RANDOMIZEDPHASE-III CLINICAL-STUDY
    International journal of hyperthermia
    
    D.G. Frew et al., "RESPONSE OF 145 SPONTANEOUS CANINE HEAD AND NECK TUMORS TO RADIATION VERSUS RADIATION PLUS MICROWAVE HYPERTHERMIA - RESULTS OF A RANDOMIZEDPHASE-III CLINICAL-STUDY", International journal of hyperthermia, 11(2), 1995, pp. 217-230
22. REEVE JG; GUADANO A; XIONG JY; MORGAN J; BLEEHEN NM
    DIMINISHED EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-5 AND ACTIVATION OF IGF-I-MEDIATED AUTOCRINE GROWTH IN SIMIAN-VIRUS 40-TRANSFORMED HUMAN FIBROBLASTS
    The Journal of biological chemistry
    
    J.G. Reeve et al., "DIMINISHED EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-5 AND ACTIVATION OF IGF-I-MEDIATED AUTOCRINE GROWTH IN SIMIAN-VIRUS 40-TRANSFORMED HUMAN FIBROBLASTS", The Journal of biological chemistry, 270(1), 1995, pp. 135-142
23. KERR DJ; RUSTIN GJ; KAYE SB; SELBY P; BLEEHEN NM; HARPER P; BRAMPTON MH
    PHASE-II TRIALS OF RHIZOXIN IN ADVANCED OVARIAN, COLORECTAL AND RENAL-CANCER
    British Journal of Cancer
    
    D.J. Kerr et al., "PHASE-II TRIALS OF RHIZOXIN IN ADVANCED OVARIAN, COLORECTAL AND RENAL-CANCER", British Journal of Cancer, 72(5), 1995, pp. 1267-1269
24. BLEEHEN NM; NEWMAN HVF; RAMPLING RP; RAMSAY JR; ROBERTS JT; BEDFORD P; NETHERSELL ABW
    A PHASE-II STUDY OF ORAL PIRITREXIM IN RECURRENT HIGH-GRADE (III, IV)GLIOMA
    British Journal of Cancer
    
    N.M. Bleehen et al., "A PHASE-II STUDY OF ORAL PIRITREXIM IN RECURRENT HIGH-GRADE (III, IV)GLIOMA", British Journal of Cancer, 72(3), 1995, pp. 766-768
25. LAURENCE VM; WARD R; DENNIS IF; BLEEHEN NM
    CARBOGEN BREATHING WITH NICOTINAMIDE IMPROVES THE OXYGEN STATUS OF TUMORS IN PATIENTS
    British Journal of Cancer
    
    V.M. Laurence et al., "CARBOGEN BREATHING WITH NICOTINAMIDE IMPROVES THE OXYGEN STATUS OF TUMORS IN PATIENTS", British Journal of Cancer, 72(1), 1995, pp. 198-205
26. HONESS DJ; BLEEHEN NM
    PERFUSION CHANGES IN THE RIF-1 TUMOR AND NORMAL-TISSUES AFTER CARBOGEN AND NICOTINAMIDE, INDIVIDUALLY AND COMBINED
    British Journal of Cancer
    
    D.J. Honess e N.M. Bleehen, "PERFUSION CHANGES IN THE RIF-1 TUMOR AND NORMAL-TISSUES AFTER CARBOGEN AND NICOTINAMIDE, INDIVIDUALLY AND COMBINED", British Journal of Cancer, 71(6), 1995, pp. 1175-1180
27. JEBB SA; OSBORNE RJ; DIXON AK; BLEEHEN NM; ELIA M
    MEASUREMENTS OF RESTING ENERGY-EXPENDITURE AND BODY-COMPOSITION BEFORE AND AFTER TREATMENT OF SMALL-CELL LUNG-CANCER
    Annals of oncology
    
    S.A. Jebb et al., "MEASUREMENTS OF RESTING ENERGY-EXPENDITURE AND BODY-COMPOSITION BEFORE AND AFTER TREATMENT OF SMALL-CELL LUNG-CANCER", Annals of oncology, 5(10), 1994, pp. 915-919
28. STEPHENS RJ; GIRLING DJ; MACHIN D; THATCHER N; BLEEHEN NM; BOLGER JJ; CLARK PI; HASLETON PS; HOPWOOD P; MACBETH FR; MOGHISSI K; SAUNDERS MI; WHITE RJ
    TREATMENT-RELATED DEATHS IN SMALL-CELL LUNG-CANCER TRIALS - CAN PATIENTS AT RISK BE IDENTIFIED
    Lung cancer
    
    R.J. Stephens et al., "TREATMENT-RELATED DEATHS IN SMALL-CELL LUNG-CANCER TRIALS - CAN PATIENTS AT RISK BE IDENTIFIED", Lung cancer, 11(3-4), 1994, pp. 259-274
29. BLEEHEN NM; BALL D; BELANI CP; BISHOP J; DOUILLARD JY; COX JD; JOHNSON DH; LECHEVALIER T; SAUNDERS MI; SHAW E; SCHAAKEKONING C; TANNOCK I; TROVO M; TURRISI AT; VANHOUTTE P
    COMBINED RADIATION AND CHEMOTHERAPY FOR UNRESECTABLE NONSMALL CELL LUNG-CARCINOMA
    Lung cancer
    
    N.M. Bleehen et al., "COMBINED RADIATION AND CHEMOTHERAPY FOR UNRESECTABLE NONSMALL CELL LUNG-CARCINOMA", Lung cancer, 10, 1994, pp. 190000019-190000023
30. FALK SJ; RAMSAY JR; WARD R; MILES K; DIXON AK; BLEEHEN NM
    BW12C PERTURBS NORMAL AND TUMOR-TISSUE OXYGENATION AND BLOOD-FLOW IN MAN
    Radiotherapy and oncology
    
    S.J. Falk et al., "BW12C PERTURBS NORMAL AND TUMOR-TISSUE OXYGENATION AND BLOOD-FLOW IN MAN", Radiotherapy and oncology, 32(3), 1994, pp. 210-217
31. SMITH PJ; SOUES S; GOTTLIEB T; FALK SJ; WATSON JV; OSBORNE RJ; BLEEHEN NM
    ETOPOSIDE-INDUCED CELL-CYCLE DELAY AND ARREST-DEPENDENT MODULATION OFDNA TOPOISOMERASE-II IN SMALL-CELL LUNG-CANCER CELLS
    British Journal of Cancer
    
    P.J. Smith et al., "ETOPOSIDE-INDUCED CELL-CYCLE DELAY AND ARREST-DEPENDENT MODULATION OFDNA TOPOISOMERASE-II IN SMALL-CELL LUNG-CANCER CELLS", British Journal of Cancer, 70(5), 1994, pp. 914-921
32. BLEEHEN NM; CALVERT AH; LEE SM; HARPER P; KAYE SB; JUDSON I; BRAMPTON M
    A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-II TRIAL OF CB10-277 GIVEN BY 24-HOUR INFUSION FOR MALIGNANT-MELANOMA
    British Journal of Cancer
    
    N.M. Bleehen et al., "A CANCER-RESEARCH CAMPAIGN (CRC) PHASE-II TRIAL OF CB10-277 GIVEN BY 24-HOUR INFUSION FOR MALIGNANT-MELANOMA", British Journal of Cancer, 70(4), 1994, pp. 775-777
33. BLEEHEN NM; GIRLING DJ; GREGOR A; LEONARD RCF; MACHIN D; MCKENZIE CG; MORGAN DAL; SMYTH JF; SPITTLE MF; STEPHENS RJ; YOSEF HMA; BOLGER JJ; CLARK PI; HASLETON PS; HOPWOOD P; MACBETH FR; MOGHISSI K; SAUNDERS MI; THATCHER N; WHITE RJ
    CAN LONG-TERM SURVIVAL BE IMPROVED IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND GOOD PERFORMANCE STATUS
    British Journal of Cancer
    
    N.M. Bleehen et al., "CAN LONG-TERM SURVIVAL BE IMPROVED IN PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC) AND GOOD PERFORMANCE STATUS", British Journal of Cancer, 70(1), 1994, pp. 142-144
34. REEVE JG; BLEEHEN NM
    [D-ARG(1), D-PHE(5), D-TRP(7,9), LEU(11)] SUBSTANCE-P INDUCES APOPTOSIS IN LUNG-CANCER CELL-LINES IN-VITRO
    Biochemical and biophysical research communications
    
    J.G. Reeve e N.M. Bleehen, "[D-ARG(1), D-PHE(5), D-TRP(7,9), LEU(11)] SUBSTANCE-P INDUCES APOPTOSIS IN LUNG-CANCER CELL-LINES IN-VITRO", Biochemical and biophysical research communications, 199(3), 1994, pp. 1313-1319
35. REEVE JG; SCHWANDER J; BLEEHEN NM
    IGFBP-2 - AN IMPORTANT REGULATOR OF INSULIN-LIKE GROWTH-FACTOR ACTIONIN HUMAN LUNG-TUMORS
    Growth regulation
    
    J.G. Reeve et al., "IGFBP-2 - AN IMPORTANT REGULATOR OF INSULIN-LIKE GROWTH-FACTOR ACTIONIN HUMAN LUNG-TUMORS", Growth regulation, 3(1), 1993, pp. 82-84
36. HONESS DJ; DENNIS IF; BLEEHEN NM
    PENTOXIFYLLINE - ITS PHARMACOKINETICS AND ABILITY TO IMPROVE TUMOR PERFUSION AND RADIOSENSITIVITY IN MICE
    Radiotherapy and oncology
    
    D.J. Honess et al., "PENTOXIFYLLINE - ITS PHARMACOKINETICS AND ABILITY TO IMPROVE TUMOR PERFUSION AND RADIOSENSITIVITY IN MICE", Radiotherapy and oncology, 28(3), 1993, pp. 208-218
37. HONESS DJ; BLEEHEN NM
    EFFECTS OF THE RADIOSENSITISING AGENT NICOTINAMIDE ON RELATIVE TISSUEPERFUSION AND KIDNEY-FUNCTION IN C3H MICE
    Radiotherapy and oncology
    
    D.J. Honess e N.M. Bleehen, "EFFECTS OF THE RADIOSENSITISING AGENT NICOTINAMIDE ON RELATIVE TISSUEPERFUSION AND KIDNEY-FUNCTION IN C3H MICE", Radiotherapy and oncology, 27(2), 1993, pp. 140-148
38. REEVE JG; MORGAN J; SCHWANDER J; BLEEHEN NM
    ROLE FOR MEMBRANE AND SECRETED INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-2 IN THE REGULATION OF INSULIN-LIKE GROWTH-FACTOR ACTION IN LUNG-TUMORS
    Cancer research
    
    J.G. Reeve et al., "ROLE FOR MEMBRANE AND SECRETED INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-2 IN THE REGULATION OF INSULIN-LIKE GROWTH-FACTOR ACTION IN LUNG-TUMORS", Cancer research, 53(19), 1993, pp. 4680-4685
39. BLEEHEN NM; GIRLING DJ; MACHIN D; STEPHENS RJ; BARLEY VL; BULLIMORE JA; WHITE RJ; BLEEHAN NM; WILLIAMS MV; BREDIN CP; DAVIDSON AR; WILLIAMS TJ; ASH DV; CLOSE HJ; JOSLIN CA; MUERS MF; STONE J; ASHFORD RF; DISCHE S; DUNPHY EP; FERMONT DC; GROSCH E; MAHER EJ; SAUNDERS MI; ADAM RJ; ALCOCK CJ; BENSON MK; HOPKIN JM; LANE DJ; HUNTER AM
    A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS
    British Journal of Cancer
    
    N.M. Bleehen et al., "A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .1. SURVIVAL AND PROGNOSTIC FACTORS", British Journal of Cancer, 68(6), 1993, pp. 1150-1156
40. BLEEHEN NM; GIRLING DJ; MACHIN D; STEPHENS RJ; HARTLEY JPR; HODSON NJ; TURTON CW; BARLEY VL; BULLIMORE JA; WHITE RJ; BLEEHEN NM; WILLIAMS MV; BREDIN CP; DAVIDSON AR; WILLIAMS TJ; ASH DV; CLOSE HJ; JOSLIN CA; MUERS MF; STONE J; ASHFORD RF; DISCHE S; DUNPHY EP; FERMONT DC; GROSCH E; MAHER EJ; SAUNDERS MI; ADAM RJ; ALCOCK CJ; BENSON MK; HOPKIN JM; LANE DJ; HUNTER AM
    A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .2. QUALITY-OF-LIFE
    British Journal of Cancer
    
    N.M. Bleehen et al., "A RANDOMIZED TRIAL OF 3 OR 6 COURSES OF ETOPOSIDE CYCLOPHOSPHAMIDE METHOTREXATE AND VINCRISTINE OR 6 COURSES OF ETOPOSIDE AND IFOSFAMIDE INSMALL-CELL LUNG-CANCER (SCLC) .2. QUALITY-OF-LIFE", British Journal of Cancer, 68(6), 1993, pp. 1157-1166